Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, intensive care, and endoscopy. The company is headquartered in South Jordan, Utah.
| Revenue (TTM) | $1.61B |
| Gross Profit (TTM) | $789.05M |
| EBITDA | $348.76M |
| Operating Margin | 14.10% |
| Return on Equity | 9.78% |
| Return on Assets | 5.04% |
| Revenue/Share (TTM) | $27.04 |
| Book Value | $29.12 |
| Price-to-Book | 3.08 |
| Price-to-Sales (TTM) | 3.24 |
| EV/Revenue | 3.53 |
| EV/EBITDA | 14.94 |
| Quarterly Earnings Growth (YoY) | 52.20% |
| Quarterly Revenue Growth (YoY) | 8.40% |
| Shares Outstanding | $59.91M |
| Float | $58.51M |
| % Insiders | 2.44% |
| % Institutions | 106.16% |
Volatility is currently expanding
Merit Medical's strong product demand, innovation and acquisitions fuel growth, while tariffs, China market pressures and competition remain key challenges.
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now?
SOUTH JORDAN, Utah, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced results from the AVF cohort of the WRAPSODY (WRAP) Global registry. Clinical data were presented during the New Innovations, Trials, Techniques & Devices session on Saturday, October 31, 2026, at the Controversies in Dialysis Access (CiDA)* conference held in Washington, DC.
Merit Medical Systems, Inc. (MMSI) Q3 2026 Earnings Call Transcript
Financial Highlights† Reported revenue of $416.2 million, up 8.4% Constant currency revenue* and constant currency revenue, organic* up 8% and up 9%, respectively GAAP operating margin of 14.1%, compared to 11.1% in prior year period Non-GAAP operating margin* of 21.3%, compared to 19.7% in prior year period GAAP EPS $0.70, up 51% Non-GAAP EPS* $1.12, up 22% Cash flow from operations of $175.2 million year-to-date Free cash flow* generation of $129.5 million year-to-date † Comparisons above are calculated for the current quarter compared with the third quarter of 2025, unless otherwise specified. Amounts stated in this release are rounded, while percentages are calculated from the underlying amounts.
SOUTH JORDAN, Utah, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in Minneapolis, Minnesota, Solo Pace manufactures temporary pacing technology designed to help physicians treat patients with aortic stenosis.
The Conestoga Small Cap Composite returned -11.22% net of fees in 3Q26, trailing the -9.39% return for the Russell 2000 Growth Index. Small Cap Composite top 5 leaders include Repligen, Merit Medical, Stevanato Group, Descartes Systems and Digi International. Small Cap Composite bottom 5 laggards include Mercury Systems, AAON, RBC Bearings, SPX Technologies and UL Solutions.
Oncology stocks are gaining relevance as cancer care evolves, with Pfizer, Merit Medical Systems and Abbott advancing treatments, diagnostics and screening technologies.
SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2026, after the close of the stock market on Thursday, October 29, 2026. Merit plans to hold its investor conference call on the same day (Thursday, October 29, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now?
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MMSI and any ticker you trade — then tracks every position and per-strategy win rate.
